<unk>  (INN) (brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall.<unk>  was the first inhibitor of fungal (1→3)-β-D-glucan synthesis to be approved by the United States Food and Drug Administration.<unk>  is administered intravenously. It is on the World Health Organization's List of Essential Medicines.
Caspofungin
Micafungin
Anidulafungin
Fluconazole
Itraconazole
Miconazole
Sertaconazole
Efinaconazole